Rhizome OS-1: Rhizome's Semi-Autonomous Operating System for Small Molecule Drug Discovery

• URL: http://arxiv.org/abs/2604.07512v2
• Date: Fri, 10 Apr 2026 23:13:52 GMT
• Title: Rhizome OS-1: Rhizome's Semi-Autonomous Operating System for Small Molecule Drug Discovery
• Abstract summary: Rhizome OS-1 is a semi-autonomous operating system for small molecule drug discovery.<n>Agents function as computational chemists, medicinal chemists, and patent agents.<n>System generates novel chemical matter directly on molecular graphs.
• Score: 5.067971847473898
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: We present Rhizome OS-1, a semi-autonomous operating system for small molecule drug discovery in which multi-modal AI agents operate as a full multidisciplinary discovery team. These agents function as computational chemists, medicinal chemists, and patent agents: they write and execute analysis code (fingerprint clustering, R-group decomposition, substructure search), visually triage molecular grids using vision capabilities, formulate explicit medicinal chemistry hypotheses across three strategy tiers, assess patent freedom-to-operate, and dynamically adapt generation strategies based on empirical screening feedback. Powered by r1 - a 246M-parameter graph diffusion model trained on 800 million molecular graphs - the system generates novel chemical matter directly on molecular graphs using fragment masking, scaffold decoration, linker design, and graph editing primitives. In two oncology campaigns (BCL6 BTB domain and EZH2 SET domain), the agent team executed 26 seeds and produced 5,231 novel molecules. Across both targets, 91.9% of generated Murcko scaffolds are absent from ChEMBL, with median Tanimoto similarity of 0.56-0.69 to the nearest known active. Boltz-2 binding affinity predictions, calibrated against ChEMBL data, achieved Spearman correlations of -0.53 to -0.64 and ROC AUC values of 0.88-0.93. These results demonstrate that semi-autonomous agent systems, equipped with graph-native generative tools and physics-informed scoring, enable a new paradigm for early-stage drug discovery: scaled, rapid, and adaptive inverse design with embedded medicinal chemistry reasoning.

Related papers

• Transcriptome-Conditioned Personalized De Novo Drug Generation for AML Using Metaheuristic Assembly and Target-Driven Filtering [0.0]
  Acute Myeloid Leukemia (AML) remains a clinical challenge due to its extreme molecular heterogeneity and high relapse rates.<n>This paper presents a novel, end-to-end computational framework that bridges the gap between patient-specific transcriptomics and de novo drug discovery.
  arXiv  Detail & Related papers  (2025-12-24T17:39:37Z)
• Learning Cell-Aware Hierarchical Multi-Modal Representations for Robust Molecular Modeling [74.25438319700929]
  We propose CHMR (Cell-aware Hierarchical Multi-modal Representations), a robust framework that models local-global dependencies between molecules and cellular responses.<n> evaluated on nine public benchmarks spanning 728 tasks, CHMR outperforms state-of-the-art baselines.<n>Results demonstrate the advantage of hierarchy-aware, multimodal learning for reliable and biologically grounded molecular representations.
  arXiv  Detail & Related papers  (2025-11-26T07:15:00Z)
• Copy-Augmented Representation for Structure Invariant Template-Free Retrosynthesis [17.5286075847689]
  C-SMILES is a novel representation that decomposes traditional SMILES into element-token pairs with five special tokens.<n>Our approach integrates SMILES alignment guidance to enhance attention consistency and ground-truth atom mapping.<n>This work establishes a new paradigm for structure-aware molecular generation with 99.9% validity in generated molecules.
  arXiv  Detail & Related papers  (2025-10-18T17:25:36Z)
• MMM: Quantum-Chemical Molecular Representation Learning for Combinatorial Drug Recommendation [5.017879531498458]
  Drug-drug interactions (DDI) between co-prescribed medications remain a significant challenge.<n>We propose Multimodal DDI Prediction with Molecular Electron Localization Function (ELF) Maps (MMM)<n>MMM combines ELF-derived features that encode global electronic properties with a bipartite graph encoder that models local substructure interactions.<n>These results demonstrate the potential complementary ELF-based 3D representations to enhance prediction accuracy and support safer drug prescribing in clinical practice.
  arXiv  Detail & Related papers  (2025-10-09T08:03:14Z)
• Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design [1.4874449172133888]
  VECTOR+ is a framework that couples property-guided representation learning with controllable molecule generation.<n>VECTOR+ generates novel, synthetically tractable candidates.<n>VECTOR+ generalizes to kinase inhibitors, producing compounds with stronger docking scores than established drugs.
  arXiv  Detail & Related papers  (2025-08-31T03:55:29Z)
• Aligned Manifold Property and Topology Point Clouds for Learning Molecular Properties [55.2480439325792]
  This work introduces AMPTCR, a molecular surface representation that combines local quantum-derived scalar fields and custom topological descriptors within an aligned point cloud format.<n>For molecular weight, results confirm that AMPTCR encodes physically meaningful data, with a validation R2 of 0.87.<n>In the bacterial inhibition task, AMPTCR enables both classification and direct regression of E. coli inhibition values.
  arXiv  Detail & Related papers  (2025-07-22T04:35:50Z)
• Bi-level Contrastive Learning for Knowledge-Enhanced Molecule Representations [68.32093648671496]
  We introduce GODE, which accounts for the dual-level structure inherent in molecules.<n> Molecules possess an intrinsic graph structure and simultaneously function as nodes within a broader molecular knowledge graph.<n>By pre-training two GNNs on different graph structures, GODE effectively fuses molecular structures with their corresponding knowledge graph substructures.
  arXiv  Detail & Related papers  (2023-06-02T15:49:45Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• ToxTree: descriptor-based machine learning models for both hERG and Nav1.5 cardiotoxicity liability predictions [0.0]
  Drug-mediated blockade of the voltage-gated potassium channel(hERG) and the voltage-gated sodium channel (Nav1.5) can lead to severe cardiovascular complications. Here, we introduce two robust 2D descriptor-based QSAR predictive models for both hERG and Nav1.5 liability predictions.
  arXiv  Detail & Related papers  (2021-12-27T00:22:37Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• Automatic design of novel potential 3CL$^{\text{pro}}$ and PL$^{\text{pro}}$ inhibitors [14.20377116532735]
  We propose a general molecule optimization framework, Molecular Neural Assay Search (MONAS) MONAS consists of three components: a property predictor which identifies molecules with specific desirable properties, an energy model which approximates the statistical similarity of a given molecule to known training molecules, and a molecule search method. In this work, these components are instantiated with graph neural networks (GNNs), Deep Energy Estorimat Networks (DEEN) and Monte Carlo tree search (MCTS)
  arXiv  Detail & Related papers  (2021-01-28T09:47:23Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.